Interrater Agreement of BT-RADS for Evaluation of Follow-up MRI in Patients with Treated Primary Brain Tumor

References

1. 1.↵
   1. Ostrom QT,
   2. Bauchet L,
   3. Davis FG, et al

   . The epidemiology of glioma in adults: a “state of the science” review. Neuro Oncol 2014;16:896–913 doi:10.1093/neuonc/nou087 pmid:24842956

   CrossRefPubMed
2. 2.↵
   1. Louis DN,
   2. Perry A,
   3. Wesseling P, et al

   . The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021;23:1231–51 doi:10.1093/neuonc/noab106 pmid:34185076

   CrossRefPubMed
3. 3.↵
   1. Willems E,
   2. Lombard A,
   3. Dedobbeleer M, et al

   . The unexpected role of Aurora A kinase in glioblastoma recurrences. Target Oncol 2017;12:11–18 doi:10.1007/s11523-016-0457-2 pmid:27573024

   CrossRefPubMed
4. 4.↵
   1. Delgado-Lopez PD,
   2. Corrales-Garcia EM

   . Survival in glioblastoma: a review on the impact of treatment modalities. Clin Transl Oncol 2016;18:1062–71 doi:10.1007/s12094-016-1497-x

   CrossRefPubMed
5. 5.↵
   1. Wu W,
   2. Klockow JL,
   3. Zhang M, et al

   . Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance. Pharmacol Res 2021;171:105780 doi:10.1016/j.phrs.2021.105780 pmid:34302977

   CrossRefPubMed
6. 6.↵
   1. Ostrom QT,
   2. Patil N,
   3. Cioffi G, et al

   . CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017. Neuro Oncol 2020;22:iv1–96 doi:10.1093/neuonc/noaa200 pmid:33123732

   CrossRefPubMed
7. 7.↵
   1. Quant EC,
   2. Wen PY

   . Response assessment in neuro-oncology. Curr Oncol Rep 2011;13:50–56 doi:10.1007/s11912-010-0143-y pmid:21086192

   CrossRefPubMed
8. 8.↵
   1. Weinberg BD,
   2. Gore A,
   3. Shu H-KG, et al

   . Management-based structured reporting of posttreatment glioma response with the brain tumor reporting and data system. J Am Coll Radiology 2018;15:767–71 doi:10.1016/j.jacr.2018.01.022 pmid:29503151

   CrossRefPubMed
9. 9.↵
   1. Malik DG,
   2. Rath TJ,
   3. Urcuyo Acevedo JC, et al

   . Advanced MRI protocols to discriminate glioma from treatment effects: state of the art and future directions. Front Radiology 2022;2:809373 doi:10.3389/fradi.2022.809373 pmid:37492687

   CrossRefPubMed
10. 10.↵
    1. Gore A,
    2. Hoch MJ,
    3. Shu HG, et al

    . Institutional implementation of a structured reporting system: our experience with the brain tumor reporting and data system. Acad Radiology 2019;26:974–80 doi:10.1016/j.acra.2018.12.023 pmid:30661977

    CrossRefPubMed
11. 11.↵
    1. Bignotti B,
    2. Calabrese M,
    3. Signori A, et al

    . Background parenchymal enhancement assessment: inter- and intra-rater reliability across breast MRI sequences. Eur J Radiology 2019;114:57–61 doi:10.1016/j.ejrad.2019.02.036 pmid:31005177

    CrossRefPubMed
12. 12.↵
    1. El Khoury M,
    2. Lalonde L,
    3. David J, et al

    . Breast imaging reporting and data system (BI-RADS) lexicon for breast MRI: interobserver variability in the description and assignment of BI-RADS category. Eur J Radiology 2015;84:71–76 doi:10.1016/j.ejrad.2014.10.003 pmid:25454100

    CrossRefPubMed
13. 13.↵
    1. Grimm LJ,
    2. Anderson AL,
    3. Baker JA, et al

    . Interobserver variability between breast imagers using the fifth edition of the BI-RADS MRI Lexicon. AJR Am J Roentgenol 2015;204:1120–24 doi:10.2214/AJR.14.13047 pmid:25905951

    CrossRefPubMed
14. 14.↵
    1. Louis DN,
    2. Perry A,
    3. Reifenberger G, et al

    . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016;131:803–20 doi:10.1007/s00401-016-1545-1 pmid:27157931

    CrossRefPubMed
15. 15.↵
    1. Gwet KL

    . Handbook of Inter-Rater Reliability: The Definitive Guide to Measuring The Extent of Agreement Among Raters. 4th Edition. Advanced Analytics, LLC; 2014.
16. 16.↵
    1. Popplewell M,
    2. Reizes J,
    3. Zaslawski C

    . Appropriate statistics for determining chance-removed interpractitioner agreement. J Altern Complement Med 2018;25:1115–20 doi:10.1089/acm.2017.0297 pmid:29851495

    CrossRefPubMed
17. 17.↵
    1. Altman DG

    . Practical Statistics for Medical Research: Taylor & Francis; 1990.
18. 18.↵
    1. Gwet KL

    . irrCAC: computing chance-corrected agreement coefficients (CAC). R package version 1.0 2019 Accessed September 18, 2023. https://CRAN.R-project.org/package=irrCAC.
19. 19.↵
    1. Parillo M,
    2. Mallio CA,
    3. Pileri M, et al

    . Interrater reliability of Brain Tumor Reporting and Data System (BT-RADS) in the follow up of adult primary brain tumors: a single institution experience in Italy. Quant Imaging Med Surg 2023;13:7423–31 doi:10.21037/qims-22-850 pmid:37969622

    CrossRefPubMed
20. 20.↵
    1. Wongpakaran N,
    2. Wongpakaran T,
    3. Wedding D, et al

    . A comparison of Cohen's kappa and Gwet AC1 when calculating inter-rater reliability coefficients: a study conducted with personality disorder samples. BMC Med Res Methodol 2013;13:61 doi:10.1186/1471-2288-13-61 pmid:23627889

    CrossRefPubMed
21. 21.↵
    1. Tong F,
    2. Tang S,
    3. Irby BJ, et al

    . The determination of appropriate coefficient indices for inter-rater reliability: using classroom observation instruments as fidelity measures in large-scale randomized research. International Journal of Educational Research 2020;99:101514 doi:10.1016/j.ijer.2019.101514

    CrossRef
22. 22.↵
    1. Elsholtz FHJ,
    2. Ro S-R,
    3. Shnayien S, et al

    . Inter- and intrareader agreement of NI-RADS in the interpretation of surveillance contrast-enhanced CT after treatment of oral cavity and oropharyngeal squamous cell carcinoma. AJNR Am J Neuroradiol 2020;41:859–65 doi:10.3174/ajnr.A6529 pmid:32327436

    Abstract/FREE Full Text
23. 23.↵
    1. Hsu D,
    2. Rath TJ,
    3. Branstetter BF, et al

    . Interrater reliability of NI-RADS on posttreatment PET/contrast-enhanced CT scans in head and neck squamous cell carcinoma. Radiology Imaging Cancer 2021;3:e200131 doi:10.1148/rycan.2021200131 pmid:34018845

    CrossRefPubMed
24. 24.↵
    1. Chung R,
    2. Rosenkrantz AB,
    3. Bennett GL, et al

    . Interreader concordance of the TI-RADS: impact of radiologist experience. AJR Am J Roentgenol 2020;214:1152–57 doi:10.2214/AJR.19.21913 pmid:32097031

    CrossRefPubMed
25. 25.↵
    1. Abidi SA,
    2. Hoch MJ,
    3. Hu R, et al

    . Using brain tumor MRI structured reporting to quantify the impact of imaging on brain tumor boards. Tomography 2023;9:859–70 doi:10.3390/tomography9020070 pmid:37104141

    CrossRefPubMed
26. 26.↵
    1. Yang Y,
    2. Yang Y,
    3. Wu X, et al

    . Adding DSC PWI and DWI to BT-RADS can help identify postoperative recurrence in patients with high-grade gliomas. J Neurooncol 2020;146:363–71 doi:10.1007/s11060-019-03387-6 pmid:31902040

    CrossRefPubMed